casino games download free

casino games download free

Tyreek Hill openly blames fantasy football for disrupting his family life

OpenAI releases text-to-video model Sora for ChatGPT Plus and Pro users

Suspense prevails in AAP as aspirants race against time

Vikings have ruled out tight end Josh Oliver. What does that mean for the running game?

Jimmy Carter, the 39th US president, has died at 100Offering a suite of industry-leading tools like Photoshop and Illustrator, this all-in-one bundle caters to graphic design, video editing, and beyond. As demand for creative work continues to rise, so does the need for affordable access to these essential tools. Fortunately, Adobe is meeting this demand with exciting offers and discounts. Here's a look at the top Adobe Creative Cloud deals in 2025, showcasing how professionals and beginners alike can maximize their creative potential. Adobe Creative Cloud is a subscription service that gives access to more than 20 creative apps, including Photoshop, Illustrator, Premiere Pro, and After Effects. All the ones engaged in graphic design, video production, web development, and digital art make extensive use of these tools. Cloud-based services of the company allow users to keep their work stored in Adobe cloud, collaborate with others through the platform, and fetch files from any number of devices. Flexible pricing makes it possible for each to reach the individual and up to the big corporation. Subscription discounts are one of the popular ways through which access is provided to Adobe Creative Cloud. The company always offers seasonal deals such as Black Friday, Cyber Monday, and end-of-year promotions wherein customers can enjoy 40% off their annual plans. Discounts apply to individual app prices as well as to the whole suite, which means even creatives needing multiple apps will be able to get them all at relatively affordable prices. For saving for longer periods, the yearly subscription is usually cheaper than a monthly subscription plan. The best deals for Adobe Creative Cloud offers can be found at key sale periods on the official website of Adobe. Students and educators receive significant benefits with Adobe's educational pricing. For a student, Adobe offers huge discounts up to 60% off the full Creative Cloud apps suite in 2025. This makes tools from Adobe accessible to new designers, video editors, and photographers looking to build up their skills without breaking a bank. Many universities and schools also partner with Adobe to offer free or discounted access to Creative Cloud for enrolled students. To such producers who operate in schools and colleges, the deal is highly advantageous, for the practice of tools at a professional level of software. One of the entry paths to tools for novice users of creative industries-the option with minimal budgets for purchases. In addition to discounted standard price offers, Adobe always has promotions and sometimes presents packages. By 2025, Creative Cloud can be available in bundles that include Adobe Stock, as a package for consumer usage of millions of premium photos, graphics, as well as videos. It helps them save time and costs on the part of creators. Free monthly trials come as part of some deals through which people can experience the application or other functions within the suite that could facilitate making one's workflow more effective, all without commitment to start. Bundles provide economic savings for professionals as well as agencies, while at the same time saving productivity. To calm those who still have doubts about subscribing, Adobe gives free trials of Creative Cloud for up to seven days. In such a trial, one gets to use the full functionality of the software and can try out its numerous tools before deciding whether or not it meets their needs. This free trial is very effective for beginners who wish to have firsthand experience before they buy a subscription. Adobe Stock, besides free trials, has a lot of benefits with most Creative Cloud subscriptions. This service provides access to a mammoth collection of assets; users can then apply such assets to a project without necessarily requiring further design, therefore saving the creators time in their quest to use the best quality visuals. The above benefits from Adobe Stock provide much value to the experience of using Creative Cloud in general. As of 2025, Adobe Creative Cloud offers multiple flexible pricing options and discounts for designers and creators at any level. With subscription discounts, educational pricing, special bundle deals, and other offers, there are many chances to access Adobe's top-notch creative tools without full price. Students and professionals can really increase productivity and creativity by making the most of these offers. Whether using the seasonal promotion or the free trial from Adobe, there are so many ways to access the software needed to make creative ideas come to life.

Containeristan or Pakistan?

Andy Cohen’s biggest gripe with CNN star and New Year’s Eve partner-in-crime Anderson Cooper? Cooper’s annual giggle fit. Cohen explained to People why the anchor’s unceasing laughter adds extra chaos throughout their annual special. “Well, [it’s] that I have to be the straight guy,” Cohen said. “Literally, he’s in a puddle of giggles for the last 90 minutes of the broadcast, and I’m the one that’s hitting all the commercial breaks.” Cohen said he turns “into Mr. CNN for the last 90 minutes” while Cooper becomes “Mr. Bravo.” “It’s a very funny role reversal,” the Bravo star said. The longtime friends have hosted the CNN event together since 2017 after former co-host Kathy Griffin was booted in the wake of backlash for posing with a mask depicting the severed head of Donald Trump. Cohen and Cooper have found themselves in various antics since then— some alcoholic , some not —leading to Cooper’s own frustrations with the Bravo host. Cooper joked on Cohen’s Watch What Happens Live earlier this month that he constantly worries about “who [Cohen’s] gonna insult and what the clean up on aisle 3 is gonna be in the morning.” Billionaire businessman Charles Dolan, who founded HBO and Cablevision and whose family owns Madison Square Garden and a number of New York City sports teams, died on Saturday—he was 98. Dolan created Cablevision Systems Corporation in 1973, merging several small Long Island cable TV systems, according to the New York Times . At the time, the company served just 1,500 customers. But when he sold it for $17.7 billion in 2015, it supplied cable TV to over three million households in the New York metropolitan area, the Times reported. He also launched HBO in the early ’70s—it was at the time a pioneering cable TV channel that offered feature-length movies with no commercials. After his death, Dolan’s family will continue to be a powerful and influential force in the worlds of media and sports. His son Patrick is the owner of Newsday , the Long Island-based newspaper he and Charles bought in 2016. The family also owns MSG in New York City and the professional sports teams that play there, the NHL’s Rangers and the NBA’s Knicks. All three entities are led by Dolan’s son James. Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Boxing Week sales are still in full swing, folks! As an avid J.Crew fan , I can honestly say that the brand’s discount-laden factory store (the brand’s online outlet) is a great way to get high-quality wardrobe staples without the big price tag. J.Crew Factory always offers discounts up to 40 percent off J.Crew, but for a limited time, you can unlock even more savings from already discounted items. Right now, J.Crew Factory is offering 70 percent off clearance items with the code SALE70 at checkout. Now’s the time to invest in evergreen staples like jeans and office-friendly blazers while they’re half off, or grab a few outwear essentials to round out your cold-weather lineup. The sale also includes tons of denim for just $50, pure cotton crewneck T-shirts for $20, and even new arrivals like NYE frocks and cashmere items. And the sale is not just for women; the gents’ and kids’ sections are equally full of additional savings. Tina Knowles sprang to her daughter Beyoncé’s defense after online trolls criticized her NFL halftime show performance on Christmas Day. Knowles clapped back at critics by reposting a message about her famous daughter on her Instagram on Friday. In the screenshot, user @iamkrisiman praised Beyoncé and wrote that “no matter how undeniably talented you are, people will always, ALWAYS, always have some negative ish to say.” Knowles cosigned the post in a lengthy caption. “It is mind-boggling to me that you would take your precious Christmas day and watch a performance of someone you hate and you don’t think has talent so that you can go talk ish about it later,” she wrote. “Obviously you are so obsessed with them, addicted to them, and secretly admire them,” she added. According to the New York Post, Knowles’ post came after some social media users called Beyoncé “overrated.” Fans and celebrities in the comments of Knowles’ response seemed to love her mama bear energy. “Period!!! Ms. T,” singer LeToya Luckett wrote. “All. Of. This!!!!!!” Oscar winner Octavia Spencer added. A post shared by Tina Knowles (@mstinaknowles) Elon Musk appeared to borrow a line from the 2008 film Tropic Thunder in an ongoing social media fight about H1B visas. Musk hit back against MAGA’s top players in a series of X posts, alleging that H1B visas are the reason why he, “and hundreds of other companies that made America strong,” are in the country. To a skeptical X user, Musk blasted: “Take a big step back and F--- YOURSELF in the face. I will go to war on this issue the likes of which you cannot possibly comprehend.” Although some were shocked by Musk’s sudden escalation—with former Trump strategist Steve Bannon calling him a “toddler”—others noticed that the disparaging remark was similar to a line in Tropic Thunder . Character Les Grossman, played by Tom Cruise, says in the film: “First, take a big step back, and literally, F--- YOUR OWN FACE ... I don’t know what kind of pan-pacific bulls--t power play you’re trying to pull here, but Asia, Jack, is my territory. So whatever you’re thinking, you’d better think again.” In response to Musk’s comment, the X user tweeted, “Bro was just memeing. I wouldn’t take it too seriously.” Nothing beats the classics pic.twitter.com/MRSdXifhH5 Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. If you’re looking to revamp your at-home fitness lineup ahead of 2025 and don’t have hours to commit to exercising each day, allow us to introduce you to the CAROL Bike . The science-backed and AI-powered fitness bike is engineered to give you maximum results in the shortest time possible—and by the shortest time, we mean as little as five minutes. In fact, according to the brand, the CAROL bike is “proven to deliver double the health and fitness benefits in 90 percent less time compared to regular cardio.” Free Returns | Free Shipping Not only is it a huge time-saver, but the CAROL Bike is also designed to be personalized to the rider’s individual fitness levels, goals, and preferences, making the workouts easy to follow, time-efficient, and super effective. CAROL’s AI and Reduced Exertion HIIT (REHIT) technology optimizes the workout to your ability and fitness level, so every second matters. The personalized, optimal resistance levels are automatically adjusted as you work out—at exactly the right time—making the most efficient workouts easy to follow. “ CAROL Bike is designed to maximize training efficiency, with the shortest, most effective workouts, backed by science. And new rider-inspired features that give riders more flexibility to exercise their way,” says Ulrich Dempfle, CEO & Co-Founder at CAROL. You can try the CAROL Bike for yourself risk-free for 100 days, and the brand offers free shipping (7-10 business days) in the U.S. Charles Shyer, the writer-director best known for directing the 1991 Steve Martin comedy Father of the Bride has died at 83. According to Deadline, Shyer died Friday and no cause of death was given by his family in a statement. “His loss leaves an unfillable hole in our lives, but his legacy lives on through his children and the five decades of wonderful work he’s left behind. We honor the extraordinary life he led and know there will never be another quite like him,” his family told the outlet. In addition to directing, Shyer gained notoriety for his screenwriting and nabbed an Oscar nomination in 1981 for co-writing the Goldie Hawn-led military comedy Private Benjamin alongside Harvey Miller, and fellow writer-director Nancy Meyers. Meyers and Shyer married in 1980 before calling it quits in 1999. They share two daughters. Other notable films co-written by Shyer include Jumpin’ Jack Flash , The Parent Trap , and Baby Boom , which he also directed. His most recent credit behind the camera was co-writing and directing the 2023 Netflix Holiday film Best. Christmas. Ever. A Norwegian chess champion left mid-tournament after refusing to change his outfit for judges. Magnus Carlsen, a five-time World Chess Champion, was competing in New York’s FIDE World Rapid and Blitz Chess Championships on Friday when he was asked to change. According to The Telegraph , Carlsen was first fined $200 for breaking the wardrobe rule before being told he would have to leave if he didn’t change. “I said, ‘I’ll change tomorrow if that’s OK.’ I didn’t even realize it today, but they said, ‘Well you have to change now.’ At that point it became a bit of a matter of principle for me,” Carlsen told chess outlet Take Take Take in an interview. “Honestly, I am too old at this point to care too much. If this is what they want to do,” he added. As for why he wore the jeans in the first place, Carlsen said he had little time to change before the tournament as he was coming from a meeting. The grandmaster made light of the debacle on X where he tweeted a photo of the now notorious jeans. “OOTD,” he captioned the snap. OOTD pic.twitter.com/9reOP6zuJv Gossip Girl star Chanel Maya Banks , who made headlines last month after denying her family’s claims that she had gone missing, has filed a restraining order against her mother and cousin. The 36-year-old submitted the request in Los Angeles on Thursday, alleging her mom, Lutchmin Judy Kumar, and cousin, Danielle Singh have harassed her, TMZ reported. The actor also claimed that her mother and cousin were working to destroy her credibility. In October, Banks’ family reported her missing. She denied the claims in a post days later. Banks wrote in the restraining order filing that Kumar and Singh broke into her apartment in November while she was gone and attacked her husband. She also alleged that an Apple AirTag was put on her car to track her. After the attack, she alleged that her mother and cousin accused her husband of murder and said that Banks should be in a psychiatric hold. Sources told TMZ that they’re happy she is safe and are “moving on with their lives.” R&B singer Ne-Yo announced Friday that a popular professional boxer under his management has died at age 35. In a joint statement posted by the Grammy-winner and the boxer’s family, Ne-Yo, real name Shaffer Chimere Smith, announced “the passing of beloved son, brother, friend and boxing champion Paul Bamba, whose light and love touched countless lives.” Hailing from Puerto Rico, Bamba became one of the first boxing talents to sign to Ne-Yo’s management company in 2024. Bamba won all of his bouts in 2024 by knock out and recently claimed WBA’s secondary “gold” cruiserweight title after knocking out Rogelio Medina. “He was a fierce yet confident competitor with an unrelenting ambition to achieve greatness. But more than anything, he was a tremendous individual who inspired many with his exceptional drive and determination,” the statement added. Bamba was the No. 12 ranked contender by the WBA and seemed set on fighting in more high profile matches—challenging boxer Jake Paul to “holla at us” in one post. Paul shared his condolences on X, writing, “RIP Paul Bamba.” RIP Paul Bamba https://t.co/ovu7egrGHn Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. 2025 is quickly approaching, and there’s no better way to celebrate the new year than with 2024’s cocktail du jour—the espresso martini. It’s the perfect way to toast 2025 with sophistication, flavor, and an energy boost. Think you can’t make the buzzy beverage at home because you’re not a bartender? Think again. You can create this beloved cocktail effortlessly with just a cocktail shaker, fresh espresso, vodka, coffee beans, and Mr Black Cold Brew Coffee Liqueur . It all starts in the land Down Under—Australia. Mr Black sources its ingredients, including 100 percent specialty-grade Arabica coffee, from local farmers and cooperatives. The liqueur is then slowly brewed with purified cold water to preserve its delicate, complex flavors. The result? A bittersweet masterpiece with bold flavor, balanced sweetness, and a lasting coffee kick. Its rich, coffee-forward taste is a crowd-pleaser, and the sleek bottle design adds a touch of elegance to any bar cart. Making an espresso martini is simple. Combine Mr Black , vodka, and freshly brewed espresso in a shaker. Add ice and shake vigorously until cold. Then, strain the mixture into a martini glass and finish with three coffee beans as a garnish. Skip the champagne toast this year and ensure you stay awake for the countdown to 2025 with a Mr Black espresso martini. Argentine-born British actress Olivia Hussey, known primarily for her role as Juliet in director Franco Zeffirelli’s 1968 film adaptation of William Shakespeare’s Romeo and Juliet , and as final girl Jess Bradford in the 1974 slasher Black Christmas , died Friday. She was 73. Friend and filmmaker Marc Huestis confirmed the news to the San Francisco Chronicle . A post on Hussey’s Instagram profile informed fans: “It is with profound sadness that we announce the passing of Olivia Hussey Eisley, who went peacefully at home surrounded by her loved ones. Olivia was a remarkable person whose warmth, wisdom, and pure kindness touched the lives of all who knew her.” Hussey was born in Buenos Aires to opera singer Andrés Osuna and Joy Hussey, a legal secretary from England. Hussey studied drama at London’s Italia Conti Academy, and was a professional actress by the time she was 13. She was 16 when she starred opposite Leonard Whiting in Romeo and Juliet —roles that earned each a Golden Globe for Most Promising Newcomer. Hussey later appeared in the films Death on the Nile, Virus, and the 1990 horror miniseries It , based on the Stephen King novel. A Democratic Florida state representative announced she is defecting from her party and joining the Republicans because the Democrats are too open to “extreme progressive voices.” Hillary Cassel, who is Jewish, said in a statement on X that she was “increasingly troubled by the Democratic Party’s failure to unequivocally support Israel” in its war with Hamas. “I’m constantly troubled by the inability of the current Democratic Party to relate to everyday Floridians,” she added. “I can no longer remain in a party that doesn’t represent my values. I know I won’t always agree on every detail with every Republican, but I do know that I will always have input, collaboration, and respect.” Cassel first won office in Florida’s 101st district in 2022, beating out her Republican opponent by seven points, according to Ballotpedia. She won re-election two months ago, running unopposed. Earlier this month, another Democrat in Florida’s house, Susan Valdes, announced that she would join the Republicans because she felt “ignored” by her party, according to the Tallahassee Democrat .

Matt Gaetz has a new gig lined up as an anchor on conservative news network OAN

NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global alzheimer's disease therapeutics market size is estimated to grow by USD 5.41 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 10.03% during the forecast period. Availability, research, and development of novel biomarkers is driving market growth, with a trend towards emergence of regenerative therapies. However, high cost of therapeutics development poses a challenge. Key market players include AB Science SA, AbbVie Inc., AgeneBio Inc., Biogen Inc., Cipla Ltd., Curasia Medilab, Denali Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Grifols SA, H Lundbeck AS, Johnson and Johnson, Lifecare Neuro Products Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., Psycogen Captab, Solco Healthcare, Teva Pharmaceutical Industries Ltd., and Aurobindo Pharma Ltd.. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth Alzheimer's disease, a leading cause of dementia among older adults, continues to be a major health concern. According to NCBI, over 6 million Americans are diagnosed with Alzheimer's and related dementias, leading to significant disability and increased deaths. The Alzheimer's disease therapeutics market is witnessing advancements in treatment with the introduction of drug classes like cholinesterase inhibitors (Aricept, Exelon, Razadyne) and Amyloid beta inhibitors (Crenezumab). Biological therapies, such as Tau antibody, are also in the pipeline. Cognitive assessment systems and smartphones aid in early diagnosis. Distribution channels, including hospitals, hospital pharmacies, online pharmacies, and e-commerce platforms, facilitate access to these drugs. Men and women, especially Medicare beneficiaries, are the primary consumers. Memantine, another drug class, targets memory impairment and thinking skills. Life expectancy and disability are significant factors driving market growth. Everyday tasks and social skills are also affected, making these therapies essential. Drug discovery techniques continue to evolve, increasing the prescription rate. Alzheimer's disease is a significant health concern for the elderly population, characterized by memory loss and cognitive decline. The disease is marked by the presence of amyloid B-peptide plaques and tau neurofibrillary tangles. Despite extensive research, no disease-modifying treatments have been discovered. Neuronal death, synaptic failure, dendritic and axonal atrophy are some of the disease's progressive symptoms. Researchers continue their efforts to find curative therapies, focusing on understanding the underlying mechanisms of neuronal damage and cognitive impairment. The Alzheimer's disease therapeutics market is currently in search of effective treatments to address this unmet medical need. Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! • Alzheimer's disease, a leading cause of dementia, affects over 6 million Americans, with numbers projected to triple by 2050. The Alzheimer's disease therapeutics market faces challenges in advancing treatment, with current options including cholinesterase inhibitors like Aricept and Exelon, and NMDA receptor antagonist Memantine. Amyloid beta inhibitors, such as Crenezumab, are in the pipeline. Behavioral skills and thinking impairments impact everyday tasks, leading to disability and increased healthcare costs for diagnosed patients. Biological therapies, like Tau antibody, show promise. Distribution channels, including hospitals, hospital pharmacies, e-commerce platforms, and online pharmacies, aim to improve access. Drug discovery techniques and cognitive assessment systems aid diagnosis among Medicare beneficiaries, mostly women. Life expectancy and memory impairment drive high prescription rates. Smartphones and the Internet facilitate access to e-commerce services, enabling easier access to these essential medications. • The Alzheimer's disease therapeutics market is significant due to the growing number of patients requiring symptomatic relief. Currently, available treatments only manage the symptoms of the disease. The pressing need for disease-modifying therapeutics arises from the increasing prevalence of Alzheimer's disease. Researchers are actively working on developing such treatments, but the high development costs and challenges in clinical trials pose obstacles to market expansion. The estimated cost of an Alzheimer's disease therapeutics development program is approximately USD5.6 billion , and the process takes around 13 years, from preclinical studies to US FDA approval. Insights into how AI is reshaping industries and driving growth- Download a Sample Report This alzheimer's disease therapeutics market report extensively covers market segmentation by 1.1 Hospital pharmacy 1.2 Retail pharmacy 1.3 E-commerce pharmacy 2.1 Cholinesterase inhibitors 2.2 N-methyl-D-aspartate receptor antagonist 2.3 Others 3.1 North America 3.2 Europe 3.3 Asia 3.4 Rest of World (ROW) 1.1 Hospital pharmacy- The hospital pharmacy segment of the Alzheimer's disease therapeutics market is experiencing significant growth due to the large-scale demand for these drugs in hospitals. This trend is driven by several factors, including increasing government investments in healthcare infrastructure in countries like India and China , the expansion of hospital facilities in developing nations, and the rising number of Alzheimer's disease cases worldwide. As a result, hospitals are becoming major distribution channels for Alzheimer's disease therapeutics. These factors collectively are expected to boost the growth of the hospital segment of the Alzheimer's disease therapeutics market during the forecast period. Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022) The Alzheimer's disease therapeutics market encompasses innovative treatments for neurodegenerative diseases, primarily Alzheimer's and dementias. Two major categories include Amyloid beta inhibitors and biological therapies. These treatments aim to slow down the progression of these conditions by targeting the buildup of beta-amyloid plaques and tau tangles in the brain. Both men and women are affected, with women making up two-thirds of the estimated 5.8 million Americans living with Alzheimer's disease. Life expectancy plays a significant role, as the majority of Medicare beneficiaries, who are aged 65 and above, are at increased risk. The prescription rate for these therapies is growing as more clinics and hospitals integrate cognitive assessment systems into their routine patient care. Memory impairment, thinking, behavioral skills, and social skills are common symptoms, affecting everyday tasks and quality of life. Alzheimer's disease, a leading cause of dementia and neurodegenerative diseases, affects memory impairment, thinking, and social skills in older adults. The Alzheimer's disease therapeutics market is witnessing significant advancements in treatment with the development of various drug classes, including cholinesterase inhibitors (Aricept, Exelon, Razadyne) and Amyloid beta inhibitors (Crenezumab). Biological therapies, such as Tau antibody, are also under investigation. Cognitive assessment systems aid in diagnosis, while distribution channels, including hospitals, hospital pharmacies, online pharmacies, and e-commerce platforms, facilitate access to these essential medications. With an increasing number of diagnosed patients, particularly among older adults, life expectancy, and Medicare beneficiaries, the prescription rate for Alzheimer's disease therapeutics continues to rise. The use of drug discovery techniques and technological advancements, such as smartphones and the Internet, are revolutionizing the way these therapies are administered and monitored. Despite these advancements, Alzheimer's disease remains a significant cause of disability and deaths, with a disproportionate impact on Men and Women. The pipeline drugs offer hope for future treatments, aiming to slow down the progression of the disease and improve the quality of life for those affected. 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation Distribution Channel Hospital Pharmacy Retail Pharmacy E-commerce Pharmacy Drug Class Cholinesterase Inhibitors N-methyl-D-aspartate Receptor Antagonist Others Geography North America Europe Asia Rest Of World (ROW) 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ SOURCE Technavio

None